| Literature DB >> 31450569 |
Sara Hurtado-Barroso1,2,3, Paola Quifer-Rada4, María Marhuenda-Muñoz1,2,3, Jose Fernando Rinaldi de Alvarenga1,3, Anna Tresserra-Rimbau2,5, Rosa M Lamuela-Raventós6,7,8.
Abstract
Consumption of organic products is increasing yearly due to perceived health-promoting qualities. Several studies have shown higher amounts of phytochemicals such as polyphenols and carotenoids in foods produced by this type of agriculture than in conventional foods, but whether this increase has an impact on humans still needs to be assessed. A randomized, controlled and crossover study was carried out in nineteen healthy subjects aged 18-40 years, who all followed an organic and conventional healthy diet, both for a 4-week period. Analysis of biological samples revealed a significant increase on the excretion of 4-hydroxybenzoic acid (4-HBA), a phenolic metabolite with biological activity, after the organic intervention. However, no changes were observed in the other variables analyzed.Entities:
Keywords: 4-HBA; carotenes; crossover study; healthy diet; humans; intervention; metals; microbiota metabolites; phenolic acid
Year: 2019 PMID: 31450569 PMCID: PMC6769758 DOI: 10.3390/antiox8090340
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Study design. OD: Organic diet; CD: Conventional diet; T0: Initial time point (before interventions); Tf: Final time point (after interventions).
Baseline characteristics of the participants (n = 38).
| Characteristics | |
|---|---|
| Males, | 9 (47) |
| Occasional intake of organic products, | 14 (74) |
| Age (years) | 30 ± 1 |
| Physical activity in leisure time (METS-min/week) | 3814 ± 489 |
| 14-item MedDiet score (points) | 9 ± 0.3 |
| Weight (kg) | 63 ± 2 |
| BMI (kg/m2) | 22.1 ± 0.4 |
| Waist (cm) | 76 ± 1 |
| WHR | 0.79 ± 0.01 |
| DBP (mmHg) | 75 ± 2 |
| SBP (mmHg) | 116 ± 2 |
| Heart rate (bpm) | 68 ± 2 |
| CRP (mg/dL) | 0.14 ± 0.03 |
| HDL (mg/dL) | 62 ± 3 |
| LDL (mg/dL) | 93 ± 5 |
| Total cholesterol (mg/dL) | 169 ± 6 |
| Triglycerides (mg/dL) | 69 ± 4 |
| Urea (mg/dL) | 29 ± 1 |
| Creatinine (mg/dL) | 0.80 ± 0.02 |
| Uric acid (mg/dL) | 4.60 ± 0.18 |
| Total proteins (g/L) | 72 ± 1 |
| Albumin (g/L) | 44 ± 0 |
Data are mean ± SEM unless otherwise specified. BMI: body mass index, WHR: waist–hip ratio, DBP: diastolic blood pressure, SBP: systolic blood pressure, CRP: C-reactive protein, HDL: high density lipoprotein, LDL: low density lipoprotein.
Nutrient and food intake of participants in both diets (n = 19).
| OD | CD |
| |
|---|---|---|---|
| Nutrient intake | |||
| Energy (kcal/d) | 1965 ± 203 | 2062 ± 204 | 0.070 |
| Carbohydrates (g/d) | 211 ± 21 | 220 ± 22 | 0.260 |
| Total fat (g/d) | 88 ± 9 | 92 ± 9 | 0.091 |
| SFA (g/d) | 22 ± 3 | 23 ± 3 | 0.064 |
| MUFA (g/d) | 45 ± 4 | 46 ± 4 | 0.136 |
| PUFA (g/d) | 12 ± 2 | 12 ± 1 | 0.136 |
| Protein (g/d) | 68 ± 9 | 72 ± 9 |
|
| Ca (mg/d) | 780 ± 111 | 847 ± 110 |
|
| Mg (mg/d) | 344 ± 37 | 353 ± 39 | 0.376 |
| P (mg/d) | 1352 ± 171 | 1433 ± 169 |
|
| Fe (mg/d) | 16 ± 1 | 16 ± 2 | 0.376 |
| Food intake | |||
| Dairy products (g/d) | 192 ± 52 | 207 ± 50 | 0.051 |
| Meat (g/d) | 98 ± 20 | 102 ± 19 | 0.202 |
| Eggs (g/d) | 28 ± 3 | 31 ± 3 | 0.180 |
| Fish and seafood (g/d) | 56 ± 16 | 66 ± 16 |
|
| Vegetables (g/d) | 296 ± 32 | 366 ± 39 | 0.055 |
| Fruits (g/d) | 360 ± 68 | 377 ± 70 | 0.650 |
| Nuts (g/d) | 13 ± 5 | 12 ± 5 | 0.950 |
| Legumes (g/d) | 26 ± 5 | 26 ± 5 | 0.528 |
| Cereals (g/d) | 98 ± 11 | 98 ± 10 | 0.717 |
| Oils (g/d) | 40 ± 4 | 40 ± 4 | 0.317 |
| Cocoa (g/d) | 18 ± 5 | 21 ± 8 | 0.812 |
| Coffee (g/d) | 62 ± 16 | 59 ± 16 | 0.600 |
| Tea (g/d) | 22 ± 7 | 17 ± 7 | 0.106 |
| Wine (g/d) | 54 ± 23 | 62 ± 28 | 0.634 |
Data are mean ± SEM. *p-value < 0.05. SFA: Saturated fatty acid, MUFA: monounsaturated fatty acid, PUFA: polyunsaturated fatty acid.
Anthropometric, clinical and biochemical measurements after the interventions (n = 19).
| OD | CD |
| |
|---|---|---|---|
| Anthropometric measurements | |||
| Weight (kg) | 64 ± 2 | 63 ± 2 | 0.365 |
| BMI | 22.1 ± 0.6 | 22.2 ± 0.6 | 0.352 |
| Waist (cm) | 76 ± 1 | 76 ± 1 | 0.549 |
| WHR | 0.80 ± 0.01 | 0.79 ± 0.01 | 0.822 |
| Clinical measurements | |||
| DBP (mmHg) | 79 ± 2 | 73 ± 2 | 0.074 |
| SBP (mmHg) | 119 ± 4 | 118 ± 3 | 0.979 |
| Heart rate (bpm) | 70 ± 3 | 66 ± 2 | 0.326 |
| Biochemical measurements | |||
| CRP (mg/dL) | 0.17 ± 0.07 | 0.26 ± 0.11 | 0.438 |
| HDL (mg/dL) | 62 ± 4 | 60 ± 4 | 0.301 |
| LDL (mg/dL) | 92 ± 9 | 90 ± 7 | 0.653 |
| Total cholesterol (mg/dL) | 168 ± 9 | 164 ± 7 | 0.494 |
| Triglycerides (mg/dL) | 66 ± 4 | 68 ± 4 | 0.421 |
| Urea (mg/dL) | 29 ± 2 | 29 ± 2 | 0.913 |
| Creatinine (mg/dL) | 0.80 ± 0.03 | 0.79 ± 0.02 | 0.763 |
| Uric acid (mg/dL) | 4.55 ± 0.29 | 4.68 ± 0.26 | 0.456 |
| Total proteins (g/L) | 73 ± 1 | 71 ± 1 | 0.145 |
| Albumin (g/L) | 44 ± 1 | 43 ± 1 | 0.136 |
Data are mean ± SEM. BMI: body mass index, WHR: waist–hip ratio, DBP: diastolic blood pressure, SBP: systolic blood pressure, CRP: C-reactive protein, HDL: high density lipoprotein, LDL: low density lipoprotein.
Inorganic elements in plasma after the interventions (n = 19).
| OD | CD |
| |
|---|---|---|---|
| Na (ppm) | 2991 ± 20 | 2992 ± 19 | 0.445 |
| K (ppm) | 839 ± 14 | 844 ± 11 | 0.778 |
| Ca (ppm) | 88 ± 1 | 88 ± 1 | 0.717 |
| Mg (ppm) | 18 ± 0 | 18 ± 0 | 0.778 |
| P (ppm) | 104 ± 3 | 100 ± 3 | 0.136 |
| Fe (ppb) | 1252 ± 127 | 1339 ± 107 | 0.601 |
| Zn (ppb) | 778 ± 98 | 785 ± 46 | 0.376 |
| Cu (ppb) | 858 ± 64 | 856 ± 71 | 0.904 |
| As (ppb) | 4.35 ± 2.27 | 3.99 ± 0.95 | 0.221 |
| Pb (ppb) | BLD | BLD | - |
| Cd (ppb) | BLD | BLD | - |
| U (ppb) | BLD | BLD | - |
Data are mean ± SEM. BLD: Below limit of detection.
Urinary phenolic acids excretion after the interventions (n = 19).
| OD | CD |
| |
|---|---|---|---|
| Phenylacetic acids | |||
| 3,4-DHPAA (nmol) | 90 ± 35 | 35 ± 9 | 0.42 |
| 3-HPAA (nmol) | 943 ± 594 | 941 ± 440 | 0.717 |
| Homovanillic (nmol) | 154 ± 60 | 108 ± 27 | 0.868 |
| Phenylpropionic acids | |||
| 3,4-HPPA (nmol) | 10 ± 3 | 27 ± 12 | 0.407 |
| DHCA (nmol) | 1.2 ± 0.4 | 1.2 ± 0.4 | 0.955 |
| Hydroxybenzoic and derivatives | |||
| 4-HBA (nmol) | 205 ± 123 | 70 ± 35 |
|
| 4-HH (nmol) | 471 ± 225 | 212 ± 85 | 0.306 |
| Hippuric (nmol) | 1281 ± 235 | 1463 ± 211 | 0.231 |
| Hydroxycinnamic and derivatives | |||
| CA (nmol) | 7 ± 2 | 10 ± 2 | 0.349 |
| m-Cou (nmol) | 0.5 ± 0.3 | 0.26 ± 0.07 | 0.501 |
| p-Cou (nmol) | 0.3 ± 0.7 | 0.54 ± 0.19 | 0.554 |
| GA (nmol) | 0.48 ± 0.45 | 0.07 ± 0.03 | 0.878 |
Data are mean ± SEM. * p-value < 0.05. 3,4-DHPAA: 3,4-dihydroxyphenylacetic acid, 3-HPAA: 3-hydroxyphenylacetic acid, 3,4-HPPA: 3-(4-hydroxyphenyl) propionic acid, DHCA: dihydrocaffeic acid, 4-HBA: 4-hydroxybenzoic acid, 4-HH: 4-hydroxyhippuric, CA: caffeic acid, m-Cou: m-coumaric acid, p-Cou: p-coumaric acid, GA: gallic acid.
Plasmatic carotenoids after the interventions (n = 19).
| OD | CD |
| |
|---|---|---|---|
| 0.39 ± 0.09 | 0.27 ± 0.06 | 0.552 | |
| 1.03 ± 0.24 | 0.95 ± 0.22 | 0.744 | |
| E-lycopene (nmol/mL) | 0.7 ± 0.17 | 0.78 ± 0.18 | 0.913 |
| Z-lycopene (nmol/mL) | 0.15 ± 0.04 | 0.20 ± 0.05 | 0.379 |
Data are mean ± SEM.